Dexatrim Diet Pills: What Happened To The Popular Weight Loss Drug?

what happened to dexatrim diet pills

Dexatrim is a brand of over-the-counter dietary supplement pills that first hit the market in the 1970s. Over the years, Dexatrim has been reformulated several times, with some ingredients being banned by the FDA due to safety concerns. Despite the lack of scientific data supporting its efficacy, Dexatrim is still available for purchase and claims to provide powerful weight loss benefits.

Characteristics Values
Brand owner Sanofi
Previous brand owners Thompson Medical, Chattem, NVE Pharmaceuticals
Years on the market More than 30 years
Ingredients Caffeine, green tea extract, Asian (Panax) ginseng root extract, dehydroepiandrosterone (DHEA), licorice root, cocoa extract, fenugreek, kelp
Side effects Acne, hair loss, facial hair growth, deeper voice in women, stomach upset, high blood pressure, myocardial injury, stroke
FDA warnings Yes
Availability Over-the-counter

shunketo

Dexatrim's original formula contained PPA, which was linked to strokes and myocardial infarction

Dexatrim is an over-the-counter dietary supplement that has been on the market for over 30 years. Its formula has changed considerably over the years. The original Dexatrim formula contained the decongestant phenylpropanolamine (PPA), which was linked to an increased risk of hemorrhagic stroke, particularly in younger women. A 2000 study by Yale University School of Medicine confirmed this link, and in the same year, the FDA requested that drug manufacturers discontinue marketing products containing PPA. Dexatrim subsequently dropped PPA from its formula.

PPA is a sympathomimetic amine that constricts blood vessels, leading to increased blood pressure. This mechanism makes it effective as a nasal decongestant and appetite suppressant. However, its ability to raise blood pressure is also associated with an increased risk of cardiovascular events, including strokes and myocardial infarction (heart attack). Several reports, including a 2003 case study, have linked the use of PPA to myocardial injury, especially when overdose is involved.

In the case study, a 25-year-old woman with no previous medical history presented with severe retrosternal chest tightness after taking Dexatrim tablets (25 mg of PPA each) twice daily for three days as an appetite suppressant for weight control. Despite stable vital signs and an unremarkable physical exam, the initial electrocardiogram indicated transient changes consistent with myocardial injury. This case highlighted the potential cardiac risks associated with PPA use, even at recommended doses.

The concerns regarding PPA in Dexatrim were not an isolated incident. As early as 1982, there were controversies and lawsuits surrounding diet pills containing PPA, with reports of strokes and hypertension. The active ingredient PPA was found in numerous over-the-counter diet pills and cold remedies, and its safety was questioned by medical professionals and regulators. Despite this, drug manufacturers defended its use, citing studies showing effectiveness and safety when used as directed.

Following the removal of PPA from Dexatrim, the formula underwent further changes. The FDA banned a second ingredient, ephedra, in 2004 due to its association with increased blood pressure and the risk of heart problems and stroke. Today, Dexatrim products contain a range of active ingredients, including caffeine, green tea extract, Asian (Panax) ginseng root extract, and dehydroepiandrosterone (DHEA). While these newer formulations do not contain PPA, they still carry the risk of side effects, adverse reactions, and drug interactions, particularly with prolonged use or higher-than-recommended doses.

shunketo

The FDA requested Dexatrim to drop PPA from its formula in 2000

Dexatrim is an over-the-counter dietary supplement that has been on the market for over 30 years. It claims to assist with weight loss, curbing binges, and controlling one's diet. The formula has changed significantly over the years, and in 2000, the FDA requested that Dexatrim discontinue the use of phenylpropanolamine (PPA) in its products.

PPA is a sympathomimetic amine commonly found in over-the-counter appetite suppressants, decongestants, and cold remedies. It works by constricting blood vessels, which can help with congestion and suppress appetite. However, it has also been linked to serious side effects, including an increased risk of hemorrhagic stroke and myocardial injury, especially in young women. In 1992, a study found that caffeine, a primary ingredient in Dexatrim, was no more effective in promoting weight loss than a placebo.

In 2000, a Yale University School of Medicine study found an association between PPA and an increased risk of hemorrhagic stroke. This study, along with other reports of adverse effects, prompted the FDA to request the removal of PPA from Dexatrim and other drug products. Dexatrim complied with the request and dropped PPA from its formula that same year.

The FDA's request was part of a larger effort to protect public health and ensure the safety of over-the-counter medications. The agency had been monitoring and raising concerns about the potential dangers of PPA as early as 1984. The removal of PPA from Dexatrim and other products was a significant step in prioritizing consumer safety and holding pharmaceutical companies accountable for the ingredients in their products.

Despite the removal of PPA, Dexatrim continued to face scrutiny for its other ingredients. In 2004, the FDA banned ephedra, another ingredient in Dexatrim, due to its association with increased blood pressure and the risk of heart problems and stroke. As of 2010, the active ingredients in Dexatrim products, including caffeine, green tea extract, and dehydroepiandrosterone (DHEA), still carry risks of side effects, adverse reactions, and adverse drug interactions, especially when used in high doses or for prolonged periods.

shunketo

Dexatrim replaced PPA with ephedrine, which was banned by the FDA in 2003

Dexatrim is an over-the-counter (OTC) dietary supplement meant to assist with weight loss. It has been on the market for over 30 years and has undergone several formula changes.

One of the original key ingredients in Dexatrim was phenylpropanolamine (PPA), a decongestant. However, concerns arose about the safety of PPA, particularly its potential link to hemorrhagic stroke. A 2000 study by Yale University School of Medicine found an increased risk of hemorrhagic stroke associated with PPA use, especially in females. As a result, the U.S. Food and Drug Administration (FDA) recommended that manufacturers voluntarily discontinue the use of PPA in their products.

In response to the FDA's request and the growing safety concerns, Dexatrim replaced PPA with ephedrine in its formula. Ephedrine is an amphetamine-like compound structurally similar to PPA. While ephedrine showed some effectiveness for short-term weight loss, it too faced scrutiny due to its potential side effects.

Ultimately, the FDA banned ephedrine in 2003 due to its association with increased blood pressure and heightened risk of heart problems and stroke. This decision forced Dexatrim to once again alter its formula, removing ephedrine and introducing alternative ingredients, such as bitter orange extract, to achieve similar effects.

Despite these formula changes, Dexatrim has consistently included caffeine as one of its active ingredients. Over time, as other active ingredients have been phased out, the concentration of caffeine in Dexatrim products has increased. However, it is important to note that studies have shown caffeine to be no more effective in promoting weight loss than a placebo when used at a dose of 200 mg daily.

shunketo

Dexatrim's current formula includes caffeine, green tea extract, and ginseng root extract

Dexatrim is an over-the-counter (OTC) dietary supplement that has been on the market for over 30 years. It is meant to assist with weight loss and curb binges. The Dexatrim formula has changed considerably over the years. Its original formula contained the decongestant phenylpropanolamine (PPA), which was associated with an increased risk of hemorrhagic stroke, especially in women. In 2000, the FDA requested that drug manufacturers discontinue marketing products containing PPA, leading to its removal from Dexatrim.

In 2004, the FDA banned a second ingredient in Dexatrim, ephedra, which was linked to increased blood pressure and a higher risk of heart problems and stroke. Dexatrim has since replaced these ingredients, and its current formula includes caffeine, green tea extract, and ginseng root extract, as well as dehydroepiandrosterone (DHEA).

Caffeine has been a part of Dexatrim's formula from the beginning, with concentrations increasing as other active ingredients were phased out. The daily recommended dose of Dexatrim products contains 50-400 mg of caffeine. While some studies have shown that caffeine can stimulate the basal metabolic rate in the short term, a 1992 double-blind placebo-controlled study found that a 200 mg daily dose of caffeine was no more effective in promoting weight loss than a placebo.

Green tea extract is another active ingredient in the current Dexatrim formula. While there is limited information on the specific effects of green tea extract in Dexatrim, green tea is known to have potential weight loss properties.

Finally, ginseng root extract, specifically Asian (Panax) ginseng root extract, is another key component of the current Dexatrim formula. Ginseng has been used for various medicinal purposes, although there is limited scientific research on its effectiveness in weight loss specifically.

shunketo

Dexatrim is not FDA-approved and may cause side effects, adverse reactions, and drug interactions

Dexatrim is a dietary supplement meant to assist with weight loss. It has been on the market for over 30 years and has undergone several formula changes. The supplement is currently owned by NVE Pharmaceuticals and is available over the counter. However, it is important to note that Dexatrim is not FDA-approved and may cause side effects, adverse reactions, and drug interactions.

The original Dexatrim formula contained the decongestant phenylpropanolamine (PPA), which was associated with an increased risk of hemorrhagic stroke, particularly in younger women. In 2000, the FDA requested that drug manufacturers discontinue marketing products containing PPA, and Dexatrim removed it from its formula. Despite this, thousands of unsolicited testimonials claimed that dietary aids containing PPA were effective, and manufacturers denied that their products caused hypertension, strokes, or psychoses.

In 2004, the FDA banned a second Dexatrim ingredient, ephedra, which was linked to increased blood pressure and a higher risk of heart problems and stroke. Dexatrim replaced ephedra with ephedrine, which was also banned by the FDA in 2003. Since then, Dexatrim has included bitter orange extract, an ingredient under study by the FDA as of 2010.

Dexatrim's current active ingredients include caffeine, green tea extract, Asian (Panax) ginseng root extract, and dehydroepiandrosterone (DHEA). While caffeine has been shown to have a short-term stimulatory effect on basal metabolic rate, a 1992 placebo-controlled study found it to be no more effective for weight loss than a placebo. DHEA, a steroid hormone, can be converted into male and female sex hormones and it is used to treat various conditions without FDA approval. Side effects of DHEA can include acne, hair loss, facial hair growth, a deeper voice in women, stomach upset, and high blood pressure, especially with long-term use.

While Dexatrim claims to provide powerful weight loss benefits, there is a lack of scientific data to support these claims. The product carries a warning about possible side effects, especially for individuals with a history of high blood pressure, and recommends consulting a qualified physician before use.

Frequently asked questions

Dexatrim is an over-the-counter dietary supplement meant to assist with weight loss. It was developed in the 1970s and gained popularity in the 1980s. Dexatrim products are currently available in capsule form and include Dexatrim Max Complex 7, Dexatrim Max Daytime Appetite Control, Dexatrim Natural Green Tea, and Dexatrim Natural Extra Energy.

The major active ingredients found in current Dexatrim products include caffeine, green tea extract, Asian (Panax) ginseng root extract, and dehydroepiandrosterone (DHEA). The original Dexatrim formula contained the decongestant phenylpropanolamine (PPA) and the amphetamine-like compound ephedra.

Dexatrim diet pills have been linked to several side effects and adverse reactions, particularly due to the PPA and ephedra content in previous formulations. PPA has been associated with an increased risk of hemorrhagic stroke and myocardial injury, especially in younger women. Ephedra was also linked to raised blood pressure and an increased risk of heart problems and strokes. As a result, both PPA and ephedra were banned by the FDA in 2000 and 2004, respectively. The current Dexatrim formula carries a warning about possible side effects, especially in patients with a history of high blood pressure.

While Dexatrim claims to provide powerful weight loss benefits, there is a lack of scientific data and FDA approval to support these claims. Some of the ingredients in Dexatrim, such as caffeine and chromium, have been associated with weight loss effects, but their concentrations in the formula may not be sufficient to induce significant results.

Dexatrim diet pills are available for purchase over the counter at various retailers, including Walmart. However, it is always recommended to consult a qualified physician or healthcare provider before taking any dietary supplement, especially if you have any pre-existing health conditions or concerns.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment